6-152141345-C-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182961.4(SYNE1):​c.25120-16G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0068 in 1,613,292 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0067 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0068 ( 83 hom. )

Consequence

SYNE1
NM_182961.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0330
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-152141345-C-A is Benign according to our data. Variant chr6-152141345-C-A is described in ClinVar as [Benign]. Clinvar id is 262192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152141345-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00668 (1017/152278) while in subpopulation AMR AF = 0.0169 (259/15298). AF 95% confidence interval is 0.0152. There are 5 homozygotes in GnomAd4. There are 521 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1017 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.25120-16G>T intron_variant Intron 138 of 145 ENST00000367255.10 NP_892006.3
SYNE1NM_001347702.2 linkc.1654-16G>T intron_variant Intron 10 of 17 ENST00000354674.5 NP_001334631.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.25120-16G>T intron_variant Intron 138 of 145 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1
SYNE1ENST00000354674.5 linkc.1654-16G>T intron_variant Intron 10 of 17 5 NM_001347702.2 ENSP00000346701.4 F8WAI0

Frequencies

GnomAD3 genomes
AF:
0.00668
AC:
1016
AN:
152160
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00191
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0170
Gnomad ASJ
AF:
0.0274
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00768
Gnomad FIN
AF:
0.000849
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.00719
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.00822
AC:
2067
AN:
251400
AF XY:
0.00851
show subpopulations
Gnomad AFR exome
AF:
0.00203
Gnomad AMR exome
AF:
0.00954
Gnomad ASJ exome
AF:
0.0249
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00918
Gnomad OTH exome
AF:
0.0137
GnomAD4 exome
AF:
0.00682
AC:
9957
AN:
1461014
Hom.:
83
Cov.:
32
AF XY:
0.00711
AC XY:
5166
AN XY:
726834
show subpopulations
Gnomad4 AFR exome
AF:
0.00176
AC:
59
AN:
33454
Gnomad4 AMR exome
AF:
0.00984
AC:
440
AN:
44694
Gnomad4 ASJ exome
AF:
0.0226
AC:
591
AN:
26124
Gnomad4 EAS exome
AF:
0.000101
AC:
4
AN:
39682
Gnomad4 SAS exome
AF:
0.00962
AC:
830
AN:
86236
Gnomad4 FIN exome
AF:
0.00167
AC:
89
AN:
53258
Gnomad4 NFE exome
AF:
0.00650
AC:
7230
AN:
1111800
Gnomad4 Remaining exome
AF:
0.00923
AC:
557
AN:
60328
Heterozygous variant carriers
0
555
1110
1666
2221
2776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00668
AC:
1017
AN:
152278
Hom.:
5
Cov.:
32
AF XY:
0.00700
AC XY:
521
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.00190
AC:
0.00190123
AN:
0.00190123
Gnomad4 AMR
AF:
0.0169
AC:
0.0169303
AN:
0.0169303
Gnomad4 ASJ
AF:
0.0274
AC:
0.0273775
AN:
0.0273775
Gnomad4 EAS
AF:
0.000386
AC:
0.000385654
AN:
0.000385654
Gnomad4 SAS
AF:
0.00789
AC:
0.00789364
AN:
0.00789364
Gnomad4 FIN
AF:
0.000849
AC:
0.000848576
AN:
0.000848576
Gnomad4 NFE
AF:
0.00719
AC:
0.00718779
AN:
0.00718779
Gnomad4 OTH
AF:
0.0156
AC:
0.0156102
AN:
0.0156102
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00917
Hom.:
4
Bravo
AF:
0.00813
Asia WGS
AF:
0.00375
AC:
13
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 06, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SYNE1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.2
DANN
Benign
0.56
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139671151; hg19: chr6-152462480; API